Outcome of Transplantation for Acute Lymphoblastic Leukemia in Children With Down Syndrome

被引:23
|
作者
Hitzler, Johann K. [1 ]
He, Wensheng [2 ]
Doyle, John [1 ]
Cairo, Mitchell [3 ]
Camitta, Bruce M. [4 ]
Chan, Ka Wah [5 ]
Diaz Perez, Miguel A. [6 ]
Fraser, Christopher [7 ]
Gross, Thomas G. [8 ]
Horan, John T. [9 ]
Kennedy-Nasser, Alana A. [10 ]
Kitko, Carrie [11 ]
Kurtzberg, Joanne [12 ]
Lehmann, Leslie [13 ]
O'Brien, Tracey [14 ]
Pulsipher, Michael A. [15 ]
Smith, Franklin O. [16 ]
Zhang, Mei-Jie [2 ]
Eapen, Mary [2 ]
Carpenter, Paul A. [17 ]
机构
[1] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[3] New York Med Coll, Valhalla, NY 10595 USA
[4] Med Coll Wisconsin, Midwest Ctr Canc & Blood Disorders, Milwaukee, WI 53226 USA
[5] Texas Transplant Inst, San Antonio, TX USA
[6] Hosp Nino Jesus, Madrid, Spain
[7] Royal Childrens Hosp, Herston, Qld, Australia
[8] Nationwide Childrens Hosp, Columbus, OH USA
[9] Childrens Healthcare Atlanta Egleston, Atlanta, GA USA
[10] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
[11] Univ Michigan, Ann Arbor, MI 48109 USA
[12] Duke Univ, Durham, NC USA
[13] Dana Farber Canc Inst, Boston, MA 02115 USA
[14] Sydney Childrens Hosp, Sydney, NSW, Australia
[15] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA
[16] Univ Cincinnati, Inst Canc, Cincinnati, OH USA
[17] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
关键词
acute lymhoblastic leukemia; Down syndrome; hematopoietic stem cell transplantation; pediatric; relapse; trisomy; 21; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; TOXICITY; FAILURE; REGIMEN; RELAPSE;
D O I
10.1002/pbc.24918
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report on 27 patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) who received allogeneic hematopoietic cell transplantation (HCT) between 2000 and 2009. Seventy-eight percent of patients received myeloablative conditioning and 52% underwent transplantation in second remission. Disease-free survival (DFS) was 24% at a median of 3 years. Post-transplant leukemic relapse was more frequent than expected for children with DS-ALL (54%) than for non-DS ALL. These data suggest leukemic relapse rather than transplant toxicity is the most important cause of treatment failure. Advancements in leukemia control are especially needed for improvement in HCT outcomes for DS-ALL. Pediatr Blood Cancer 2014;61:1126-1128. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:1126 / 1128
页数:3
相关论文
共 50 条
  • [21] Outcome of acute lymphoblastic leukemia in children with down syndromePolish pediatric leukemia and lymphoma study group report
    Zawitkowska, Joanna
    Odoj, Teresa
    Drabko, Katarzyna
    Zaucha-Prazmo, Agnieszka
    Rudnicka, Julia
    Romiszewski, Michal
    Matysiak, Michal
    Kwiecinska, Kinga
    Cwiklinska, Magdalena
    Balwierz, Walentyna
    Owoc-Lempach, Joanna
    Derwich, Katarzyna
    Wachowiak, Jacek
    Niedzwiecki, Maciej
    Adamkiewicz-Drozynska, Elzbieta
    Trelinska, Joanna
    Mlynarski, Wojciech
    Koltan, Andrzej
    Wysocki, Mariusz
    Tomaszewska, Renata
    Szczepanski, Tomasz
    Plonowski, Marcin
    Krawczuk-Rybak, Maryna
    Ociepa, Tomasz
    Urasinski, Tomasz
    Mizia-Malarz, Agnieszka
    Sobol-Milejska, Grazyna
    Karolczyk, Grazyna
    Kowalczyk, Jerzy
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2017, 34 (04) : 199 - 205
  • [22] The acute lymphoblastic leukemia of Down Syndrome - Genetics and pathogenesis
    Izraeli, Shai
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2016, 59 (03) : 158 - 161
  • [23] MYELOFIBROSIS AND ACUTE LYMPHOBLASTIC LEUKEMIA IN A CHILD WITH DOWN SYNDROME
    NORDAN, UZ
    HUMBERT, JR
    JOURNAL OF PEDIATRICS, 1979, 94 (02): : 253 - 255
  • [24] Outcome of Tumor Lysis Syndrome with Hydration and Alkalinization in Children with Acute Lymphoblastic Leukemia
    Sultana, A.
    Islam, A.
    Akhtar, G.
    Ma, Rahman
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2012, 11 (04): : 284 - 291
  • [25] Acute leukemia in Down syndrome children
    Toll, T
    Estella, J
    Illa, J
    Alcorta, I
    Mateo, M
    CYTOGENETICS AND CELL GENETICS, 1997, 77 : 25 - 26
  • [26] Acute leukemia in children with Down syndrome
    Xavier, Ana C.
    Taub, Jeffrey W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1043 - 1045
  • [27] Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia
    Bohnstedt, C.
    Levinsen, M.
    Rosthoj, S.
    Zeller, B.
    Taskinen, M.
    Hafsteinsdottir, S.
    Bjorgvinsdottir, H.
    Heyman, M.
    Schmiegelow, K.
    LEUKEMIA, 2013, 27 (04) : 866 - 870
  • [28] Epigenome-Wide Association Study of Acute Lymphoblastic Leukemia in Children with Down Syndrome
    Li, Shaobo
    Sok, Pagna
    Xu, Keren
    Muskens, Ivo S.
    Elliott, Natalina
    Myint, Swe Swe
    Pandey, Priyatama
    Hansen, Helen M.
    Morimoto, Libby M.
    Kang, Alice Y.
    Metayer, Catherine
    Ma, Xiaomei
    Mueller, Beth A.
    Roy, Anindita
    Roberts, Irene
    Rabin, Karen R.
    Brown, Austin L.
    Lupo, Philip J.
    Wiemels, Joseph L.
    de Smith, Adam J.
    BLOOD, 2021, 138
  • [29] Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia
    C Bohnstedt
    M Levinsen
    S Rosthøj
    B Zeller
    M Taskinen
    S Hafsteinsdottir
    H Björgvinsdóttir
    M Heyman
    K Schmiegelow
    Leukemia, 2013, 27 : 866 - 870
  • [30] Epigenome-wide association study of acute lymphoblastic leukemia in children with Down syndrome
    Li, Shaobo
    Sok, Pagna
    Xu, Keren
    Muskens, Ivo S.
    Elliott, Natalina
    Myint, Swe Swe
    Pandey, Priyatama
    Hansen, Helen M.
    Morimoto, Libby M.
    Kang, Alice Y.
    Metayer, Catherine
    Ma, Xiaomei
    Mueller, Beth A.
    Roy, Anindita
    Roberts, Irene
    Rabin, Karen R.
    Brown, Austin L.
    Lupo, Philip J.
    Wiemels, Joseph L.
    de Smith, Adam J.
    BLOOD ADVANCES, 2022, 6 (14) : 4132 - 4136